Canada probing whether delaying second COVID-19 vaccine doses could help more people
OTTAWA -- Canada's chief public health officer says she has asked the national vaccine advisory panel to investigate if there is merit to delaying second doses of COVID-19 vaccines in a bid to get more people vaccinated faster with first doses.
The request comes after the United Kingdom said it will delay the second doses of vaccines from Pfizer-BioNTech and AstraZeneca, up to 12 weeks.
Pfizer-BioNTech's product is supposed to be given in two doses 21 days apart, and AstraZeneca's in two doses 28 days apart.
Health Canada has not yet authorized AstraZeneca's vaccine candidate but approved Pfizer-BioNTech's on Dec. 9 and another from Massachusetts-based biotech firm Moderna on Dec. 23.
A written statement from Pfizer says ultimately alternative dosing decisions are up to local health authorities, but that the company has no evidence protection after the first dose remains in place after 21 days.
Tam says the National Advisory Committee on Immunization is being asked to provide analysis on what is known about the dosing regimens and what should be considered in deciding whether or not to delay the second doses.
Mia Rabson, The Canadian Press
- First doses of Pfizer COVID-19 vaccine, not yet approved, to land in Canada next week
- Canada signs deals with Pfizer, Moderna to get doses of COVID-19 vaccines
- Health Canada approves Pfizer’s COVID-19 vaccine
- Pfizer-BioNTech delays vaccine deliveries to Canada due to production issues
- Canada signs deal with Novovax to get 76 million doses of COVID-19 vaccine
- Charges laid after rescuing a raccoon being held captive in Burlington
- Mississauga woman speechless after massive lottery win
- New bus corridor and three new stations coming to Mississauga
- 121 workers at Mississauga's Gateway postal facility test positive for COVID-19
- Subway can press $210-million defamation suit against CBC for show on chicken content